English
Specials
    Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsBusinessStocksAlkem Laboratories shares fall 0.62% amid high volume

    Alkem Laboratories shares fall 0.62% amid high volume

    Alkem Laboratories shares traded at Rs 5,355.00, with a slight decline amid high trading volume.

    Alpha Desk
    August 14, 2025 / 15:07 IST
    Disclaimer This is an AI-assisted live blog with updates from multiple sources Disclaimer
       
       
      26 Aug, 2025 12:21
      Volume
      Todays L/H
      More

      Shares of Alkem Laboratories experienced a decline of 0.62%, trading at Rs 5,355.00 in Thursday's session. The stock witnessed high volume and a surge in trading activity.

      Financial Snapshot:

      Alkem Laboratories has demonstrated consistent financial performance over the past few years. Here’s an overview of their consolidated financials:

      Quarterly Performance:

      HeadingJun 2024Sep 2024Dec 2024Mar 2025Jun 2025
      RevenueRs 3,031.82 CroreRs 3,414.67 CroreRs 3,374.28 CroreRs 3,143.75 CroreRs 3,371.14 Crore
      Net ProfitRs 550.24 CroreRs 701.96 CroreRs 640.79 CroreRs 323.01 CroreRs 668.32 Crore
      EPS45.6057.6052.3425.5755.56

      The revenue for the quarter ending June 2025 was Rs 3,371.14 Crore, compared to Rs 3,143.75 Crore for the quarter ending March 2025, marking an increase. The net profit for the same period was Rs 668.32 Crore, up from Rs 323.01 Crore in the previous quarter.

      Annual Performance:

      Heading20212022202320242025
      RevenueRs 8,865.01 CroreRs 10,634.19 CroreRs 11,599.26 CroreRs 12,667.58 CroreRs 12,964.52 Crore
      Net ProfitRs 1,617.77 CroreRs 1,680.32 CroreRs 1,006.81 CroreRs 1,811.46 CroreRs 2,216.00 Crore
      EPS132.57137.6382.31150.19181.11
      BVPS632.20740.05789.21896.231,002.50
      ROE21.4819.0510.8817.4118.06
      Debt to Equity0.230.300.140.120.09

      The annual revenue for the year ending March 2025 was Rs 12,964.52 Crore, an increase from Rs 12,667.58 Crore in the previous year. Net profit also increased to Rs 2,216.00 Crore from Rs 1,811.46 Crore over the same period. The Debt to Equity ratio has decreased from 0.12 in 2024 to 0.09 in 2025.

      Annual Income Statement:

      Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
      SalesRs 12,964 CroreRs 12,667 CroreRs 11,599 CroreRs 10,634 CroreRs 8,865 Crore
      Other IncomeRs 493 CroreRs 310 CroreRs 216 CroreRs 162 CroreRs 233 Crore
      Total IncomeRs 13,458 CroreRs 12,978 CroreRs 11,815 CroreRs 10,796 CroreRs 9,098 Crore
      Total ExpenditureRs 10,809 CroreRs 10,842 CroreRs 10,403 CroreRs 8,900 CroreRs 7,197 Crore
      EBITRs 2,648 CroreRs 2,135 CroreRs 1,412 CroreRs 1,896 CroreRs 1,901 Crore
      InterestRs 121 CroreRs 112 CroreRs 107 CroreRs 52 CroreRs 58 Crore
      TaxRs 311 CroreRs 211 CroreRs 297 CroreRs 163 CroreRs 224 Crore
      Net ProfitRs 2,216 CroreRs 1,811 CroreRs 1,006 CroreRs 1,680 CroreRs 1,617 Crore

      The company’s sales increased from Rs 12,667 Crore in March 2024 to Rs 12,964 Crore in March 2025.

      Quarterly Income Statement:

      Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
      SalesRs 3,371 CroreRs 3,143 CroreRs 3,374 CroreRs 3,414 CroreRs 3,031 Crore
      Other IncomeRs 136 CroreRs 145 CroreRs 92 CroreRs 134 CroreRs 120 Crore
      Total IncomeRs 3,507 CroreRs 3,289 CroreRs 3,467 CroreRs 3,549 CroreRs 3,152 Crore
      Total ExpenditureRs 2,706 CroreRs 2,864 CroreRs 2,700 CroreRs 2,740 CroreRs 2,503 Crore
      EBITRs 800 CroreRs 424 CroreRs 767 CroreRs 808 CroreRs 648 Crore
      InterestRs 29 CroreRs 28 CroreRs 36 CroreRs 28 CroreRs 29 Crore
      TaxRs 102 CroreRs 73 CroreRs 90 CroreRs 78 CroreRs 69 Crore
      Net ProfitRs 668 CroreRs 323 CroreRs 640 CroreRs 701 CroreRs 550 Crore

      The sales for the quarter ending June 2025 increased to Rs 3,371 Crore compared to Rs 3,143 Crore in March 2025.

      Cash Flow:

      Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
      Operating ActivitiesRs 1,912 CroreRs 1,948 CroreRs 1,682 CroreRs 1,111 CroreRs 1,264 Crore
      Investing ActivitiesRs -1,298 CroreRs -1,008 CroreRs 112 CroreRs -1,435 CroreRs -998 Crore
      Financing ActivitiesRs -810 CroreRs -1,145 CroreRs -1,760 CroreRs 379 CroreRs -271 Crore
      OthersRs 10 CroreRs -2 CroreRs 7 CroreRs 2 CroreRs 3 Crore
      Net Cash FlowRs -186 CroreRs -207 CroreRs 41 CroreRs 57 CroreRs -1 Crore
      Balance Sheet:
      Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
      Equities & Liabilities
      Share CapitalRs 23 CroreRs 23 CroreRs 23 CroreRs 23 CroreRs 23 Crore
      Reserves & SurplusRs 11,960 CroreRs 10,268 CroreRs 9,021 CroreRs 8,613 CroreRs 7,351 Crore
      Current LiabilitiesRs 3,964 CroreRs 3,994 CroreRs 3,707 CroreRs 4,805 CroreRs 3,604 Crore
      Other LiabilitiesRs 1,741 CroreRs 1,287 CroreRs 1,004 CroreRs 625 CroreRs 539 Crore
      Total LiabilitiesRs 17,691 CroreRs 15,574 CroreRs 13,756 CroreRs 14,069 CroreRs 11,519 Crore
      Assets
      Fixed AssetsRs 2,977 CroreRs 2,614 CroreRs 2,592 CroreRs 2,838 CroreRs 2,790 Crore
      Current AssetsRs 10,945 CroreRs 10,411 CroreRs 8,729 CroreRs 8,435 CroreRs 6,928 Crore
      Other AssetsRs 3,768 CroreRs 2,548 CroreRs 2,434 CroreRs 2,795 CroreRs 1,799 Crore
      Total AssetsRs 17,691 CroreRs 15,574 CroreRs 13,756 CroreRs 14,069 CroreRs 11,519 Crore
      Other Info
      Contingent LiabilitiesRs 995 CroreRs 210 CroreRs 410 CroreRs 425 CroreRs 449 Crore
      Financial Ratios:
      RatioMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
      Basic EPS (Rs.)132.57137.6382.31150.19181.11
      Diluted EPS (Rs.)132.57137.6382.31150.19181.11
      Book Value /Share (Rs.)632.20740.05789.21896.231,002.50
      Dividend/Share (Rs.)30.0034.0050.0040.0045.00
      Face Value22222
      Gross Profit Margin (%)24.5420.8315.7320.1823.18
      Operating Margin (%)21.4417.9713.0617.8120.43
      Net Profit Margin (%)18.2415.808.6714.2917.09
      Return on Networth (%)21.4819.0510.8817.4118.06
      ROCE (%)24.0120.6315.0719.4919.29
      Return On Assets (%)13.7511.697.1511.5212.24
      Current Ratio (X)1.921.762.352.612.76
      Quick Ratio (X)1.281.131.651.942.02
      Debt to Equity (x)0.230.300.140.120.09
      Interest Coverage Ratios (X)32.2642.3117.0022.7424.70
      Asset Turnover Ratio (%)76.950.720.830.860.78
      Inventory Turnover Ratio (X)3.831.331.091.254.64
      3 Yr CAGR Sales (%)17.4920.2317.9019.5410.41
      3 Yr CAGR Net Profit (%)59.1947.38-6.405.8214.84
      P/E (x)20.8926.3141.2632.9026.95
      P/B (x)4.495.014.495.734.87
      EV/EBITDA (x)15.1719.6121.7523.1219.39
      P/S (x)3.744.073.504.664.50
      Corporate Actions:
      • August 12, 2025: Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome. The audio recording of the Earnings Call for Q1FY26 is available.
      • August 12, 2025: Closure of Trading Window. The trading window will open on August 18, 2025, following the communication of the Financial Results for the quarter ended June 30, 2025, to the Stock Exchange.
      • August 12, 2025: Announcement under Regulation 30 (LODR)-Investor Presentation. Press release and analyst presentation on Q1FY26 earnings and business updates are enclosed.

      Alkem Laboratories announced a final dividend of Rs 8 per share (400%) with an effective date of August 8, 2025. Additionally, an interim dividend of Rs 37 per share (1850%) was announced on January 28, 2025, with an effective date of February 14, 2025.

      Moneycontrol analysis, as of August 12, 2025, indicates a very bullish sentiment on the stock.

      Alkem Laboratories shares traded at Rs 5,355.00, with a slight decline amid high trading volume.

      Alpha Desk
      first published: Aug 14, 2025 03:07 pm

      Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

      Subscribe to Tech Newsletters

      • On Saturdays

        Find the best of Al News in one place, specially curated for you every weekend.

      • Daily-Weekdays

        Stay on top of the latest tech trends and biggest startup news.

      Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347